Research Article
Baseline Characteristics of Fabry Disease “Amenable” Migalastat Patients in Argentinian Cohort
Figure 2
Plasma Lyso-Gb3 levels (a) and α-galactosidase-A activity (b) according to gender and Fabry disease phenotype. Alpha-GalA: α-galactosidase-A; M: males; F: females.
| (a) |
| (b) |